ALNY vs QMCO · P/E 76, rev $1.29B vs rev $279.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Quantum Corporation (QMCO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Quantum Corporation (QMCO) is a computer hardware company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported QMCO revenue for 2026-03-31 was $279.6M. Net income was -$101.0M. Revenue was up 2.0% from 2025-03-31 to 2026-03-31. QMCO currently screens at market cap $218.8M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. QMCO currently screens at market cap $218.8M.
Not investment advice. Open the ALNY and QMCO stock pages for the full models.
Not investment advice.